Klimadynon

Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent, the active ingredient in Klimadynon, is a herbal botanical presented as a dry extract for oral use. It is traditionally employed to support women experiencing menopausal and menstrual‑related symptoms.

GNH USA supplies Klimadynon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Clients benefit from reliable delivery timelines and comprehensive post‑marketing support.

Klimadynon, containing a Cimicifuga racemosa extract, is used to address symptoms associated with hormonal fluctuations in women.

- Menopausal vasomotor symptoms: reduces frequency and severity of hot flashes and night sweats. - Premenstrual syndrome (PMS): may alleviate mood swings, breast tenderness and irritability. - Mild menstrual irregularities: supports regulation of the menstrual cycle and eases associated discomfort.

Adverse reactions reported with Klimadynon are generally mild, but rare serious events have been documented.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort. - Headache. - Dizziness. - Skin rash or mild itching. - Mild fatigue.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe allergic reaction: anaphylaxis, angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant bleeding when combined with anticoagulants. - Acute hypertension in susceptible individuals.

Before using Klimadynon, consider the following precautions:

- Pregnancy: avoid use due to insufficient safety data. - Breastfeeding: not recommended as transfer to milk is unknown. - Liver disease: use with caution; monitor hepatic function. - Hormone‑sensitive conditions: avoid in estrogen‑dependent tumors. - Drug interactions: review concomitant medications for potential synergy. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and direct sunlight.

Klimadynon may interact with several drug classes; awareness of the interaction level is essential.

Major Interactions (Avoid): - Estrogen replacement therapy: additive hormonal effects may increase risk of estrogen‑related adverse events. - Anticoagulants (e.g., warfarin): potential for enhanced bleeding. - Strong CYP3A4 inhibitors: may raise plasma levels of active constituents.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible serotonergic synergy affecting mood. - Antihypertensive agents: may potentiate blood pressure lowering. - Diuretics: monitor electrolyte balance. - Herbal supplements with similar phytoestrogen content: assess cumulative hormonal activity.